Transaction DateRecipientSharesTypePriceValue
7th January 2021Advisors Llc Orbimed2,000,000Open or private sale$3.50$7,000,000.00
28th December 2020Advisors Llc Orbimed600,000Open or private sale$14.25$8,550,000.00
8th December 2020Advisors Llc Orbimed2,493,741Conversion of derivative$0.00
8th December 2020Advisors Llc Orbimed21,400Open or private sale$1.96$41,944.00
8th December 2020Advisors Llc Orbimed1,055,287Conversion of derivative$0.00
8th December 2020Advisors Llc Orbimed952,377Open or private purchase$21.00$19,999,917.00
8th December 2020Advisors Llc Orbimed238,100Open or private purchase$21.00$5,000,100.00
8th December 2020Advisors Llc Orbimed21,400Exercise of in-the-money or at-the-money derivatives securities (usually options)$0.96$20,544.00
8th December 2020Advisors Llc Orbimed3,462,737Conversion of derivative$0.00
7th December 2020Advisors Llc Orbimed118,794Conversion of derivative$0.00
Sc Pharmaceuticals
Sc Pharmaceuticals logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.

scPharmaceuticals, Inc. was founded by Pieter Muntendam and Bertram Pitt in February 2013. Its products include furosemide, used as parenteral diuretic in treating heart failure.

Ticker: SCPH
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1604950
Employees: 17
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags